L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
about
Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer.Plasma membrane proteomics of human breast cancer cell lines identifies potential targets for breast cancer diagnosis and treatment.Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT.L1CAM in human cancer.L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor.PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort studyTranscriptional profiles of pilocytic astrocytoma are related to their three different locations, but not to radiological tumor features.Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial CarcinomaL1CAM as a prognostic marker in stage I endometrial cancer: a validation study.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas.USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.Endometroid carcinoma developing in endometriosis over the symphysis pubis.Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer.Evaluating L1CAM expression in human endometrial cancer using qRT-PCR.The sL1CAM in sera of patients with endometrial and ovarian cancers.Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma.Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors.Factors predicting recurrent endometrial cancer.Adjuvant therapy for endometrial cancer.Current status of molecular biomarkers in endometrial cancer.Proteomics of endometrial cancer diagnosis, treatment, and prognosis.Update on pathology, staging and molecular pathology of endometrial (uterine corpus) adenocarcinoma.Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.L1 cell adhesion molecule as a therapeutic target in cancer.L1CAM: amending the "low-risk" category in endometrial carcinoma.Endometrial cancer: Not your grandmother's cancer.Prognostic significance of L1 cell adhesion molecule in cancer patients: A systematic review and meta-analysis.L1CAM in the Early Enteric and Urogenital System.L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.L1CAM expression in endometrial carcinomas: an ENITEC collaboration study.Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.The Significance of L1CAM Expression in Clear Cell Carcinoma of the Endometrium.Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.Cell Recognition Molecule L1 Regulates Cell Surface Glycosylation to Modulate Cell Survival and Migration.L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer.Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomas.L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
P2860
Q33648936-D11AEED3-9BFD-49A2-87CE-316EA2893C9DQ33910532-0EBB07BB-4C98-44EA-B049-4D307F3F1D0CQ34439193-4E89EF29-3EE9-48E8-8164-00E9298E2123Q34482366-1CA263DF-01FC-4F7B-AD0B-6C0CF6626CFFQ34995243-D0CDE346-9E61-458D-9902-68659E5AD934Q35678094-BF659357-4AC7-4AC0-94AE-C52F8130B059Q35819975-F9D8248A-9A3D-4CF5-BFEE-345934621FC4Q35924210-262B6F31-2502-4533-8AF0-E479B3E6F60CQ35927619-02853946-D513-489B-801D-FAD57D58AE29Q36094419-A6633586-EEC2-4A28-B0A6-21DA74FEF9AFQ36372293-81BDD0B9-2AC1-4365-BF07-C476BBDBDDD6Q37295623-BF9FC976-8DA7-463E-98DA-D56A941B8C48Q37327636-97114BE4-CDF3-4758-83F2-23C2FC2A0AD8Q37390330-A29FDAF1-F6A0-4E0C-9C7D-36B0A5E060A5Q37392946-F3BEF027-BC73-40D9-AAB6-B55AFC4D18C0Q37457845-5642AAC0-DE2A-43B5-8854-5BFE61B71D86Q37578356-B53B00B7-2CED-4FB4-96A2-745E13FD2904Q37660308-DEEDBD7A-604A-48BA-B9C6-7B0FD017D8FCQ37682775-593BA113-7350-4087-8155-A219BA496720Q37703894-9148445A-3A7E-409F-82E4-4C6BF1432C7CQ37717743-75E137BA-7654-417E-B6F9-DD3DCADF938BQ38234228-0A34462E-ABE3-4C7F-8752-A0A36D3529A3Q38626386-ADCF4362-FF15-4B7D-8469-A233F559B899Q38628862-72052D84-023A-4175-A527-F81484DA0A82Q38677937-4B5F49D1-BEE2-4BAE-9714-33E407709285Q38701631-E531E38B-A402-4FE7-AA80-6EE28461A8FCQ38815450-63F691B4-06AB-425E-8DF5-961F55C86793Q38852405-1F2AC8A1-F217-45EA-A6DA-E9B8AD3CD708Q39004897-4CC20E53-B75A-4CE3-A636-522D91046B49Q39062702-0E2E984F-880F-488D-A24F-919BA8B4CAF8Q40009522-DD62E12F-539E-4BE8-801A-7B5B96120629Q40104862-CF6BCD16-97E6-4788-BDA0-CDF74D1C1D0FQ40629455-223C9792-29FD-46F8-A9D4-096EE4A7233DQ40992668-F42D0629-570A-44A4-BB72-D0AB6962532AQ44324745-1D605F0E-B38A-4843-9C6E-82B50A715F80Q46764265-AD1B5BBB-4008-4C04-AB82-DD62C1525B6DQ47104437-6D2CB406-2ECA-4C4D-B354-BA2EE354BAC9Q47110513-B9A9BBA8-3967-45C6-A588-9DE680E41A08Q47159073-5238908A-D23E-4B34-911C-D14C3E3B7C78Q47757908-8F39DF90-3387-4350-B89D-A1AC48AD6B68
P2860
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
L1CAM in early-stage type I en ...... large multicenter evaluation.
@en
L1CAM in early-stage type I en ...... large multicenter evaluation.
@nl
type
label
L1CAM in early-stage type I en ...... large multicenter evaluation.
@en
L1CAM in early-stage type I en ...... large multicenter evaluation.
@nl
prefLabel
L1CAM in early-stage type I en ...... large multicenter evaluation.
@en
L1CAM in early-stage type I en ...... large multicenter evaluation.
@nl
P2093
P2860
P50
P3181
P356
P1476
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation
@en
P2093
Alain G Zeimet
Alexander Reinthaller
Alexandra Meuter
Alon Ben-Arie
Andrea Mariani
Boris Winterhoff
Christian Marth
Daniel Reimer
Edgar Petru
Elisa Lappi-Blanco
P2860
P304
P356
10.1093/JNCI/DJT144
P407
P577
2013-06-18T00:00:00Z